The DEA’s June 29 Hearing Explained: What Full Cannabis Rescheduling Would Mean for Medical Patients
A federal DEA hearing beginning June 29, 2026 will determine whether all cannabis -- not just state-licensed medical marijuana -- moves from Schedule I to Schedule III. Here's what already changed on April 28, what the hearing is actually deciding, and…
CBD Gummies Effectiveness: What Real-World Use and Research Actually Show
✦ New CED Clinical Relevance #57 Clinical Context Background information relevant to the evolving cannabis medicine landscape. CBDResearchSleepAnxietyDosingSafetyHemp Why This Matters Clinicians need to understand that CBD gummies show…
Cannabis Insurance and the Fight for Patient Access | Sponsored | rutlandherald.com
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainAnxietyMental HealthPolicyResearchIndustrySafety Clinical Summary # Clinical Summary Insurance coverage remains a…
Medical Cannabis: Demystifying the Treatment and Changing Lives #shorts
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainAnxietyMental HealthResearchSafetyNeurologyPolicy Clinical Perspective 🏥 While testimonial-based content about…
Medical Cannabis: Doctors Prescribe Little THC and CBD #shorts
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCDosingSafetyPolicyPain Why This Matters Clinicians need to understand that CBD monotherapy has limited…
![Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/06/ced-pexels-4226264-1.jpg?resize=440%2C310&ssl=1 "Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] – EMBL-EBI")
Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] – EMBL-EBI
✦ New CED Clinical Relevance #62 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologySafetyMental HealthCBDTHCAnxiety Why This Matters This research characterizing MAGL (monoacylglycerol…
Study Found Teen Cannabis Use Interferes with the Brain’s Reward System
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyTHCMental HealthPediatricsSafetyAnxiety Why This Matters Clinicians should understand that adolescent…
CBD for Skin Care: Evidence-Based Benefits & Research
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. CBDResearchAgingSafetyHempAnxietyMental Health Why This Matters Clinicians need to understand CBD’s mechanism in…
Using cannabis for sleep isn’t harmless – it can trap people in a cycle of dependency
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. SleepTHCSafetyMental HealthResearchDosingAnxiety Why This Matters Clinicians should understand that cannabis does not…
It may be legal for adults, but cannabis use a danger to young brains
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchPediatricsMental HealthSafetyNeurologyTHC Why This Matters Clinicians need to understand that legal adult…